Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales

Now watching

Next video starts in : 7 Play

Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales

Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales
Replay video
Up next

SNL's Controversial Ad Parody

Unlock your personal NFL Now stream by signing in to NFL.com

Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales

by TheStreet.com Videos 0:50 mins

Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales

by TheStreet.com Videos 0:50 mins

Sales of medical diagnostics and vascular products in the second quarter helped Abbott Laboratories beat expectations. As a result, shares are trading up on Wednesday. Revenue rose roughly 2% to more than $5.5 billion. Abbott earned $0.30 cents a share in the second quarter, exactly the same as one year ago. Abbott spokesperson Scott Stoffel said, “Our gross margins were better than some expected due to underlying improvement in diagnostics and vascular products." But, taxes on earnings more than doubled to $277 million. Nonetheless, CEO Miles D. White said he is optimistic going into the second half of this year and said will continue to focus on cost saving efforts. TheStreet's Julia Sun reports from New York.

Videos For You

Community

  1. 2:56

    Community Season Six Trailer Premiere

  2. 2:30

    Community 401 - Season 4: Senior Year

  3. 3:05

    Community 301 - Season 3: Junior Year

  4. 2:56

    Community 201 - Season 2: Sophomore Year

  5. 3:02

    Community 101 - Season 1: Freshman Year

  6. 2:00

    Community Cast Announce the Season 6 Premiere Date